PCI-32765 RacemateBTK inhibitor CAS# 936563-87-0 |
2D Structure
- Btk inhibitor 1 R enantiomer
Catalog No.:BCC5125
CAS No.:1022150-12-4
- AVL-292
Catalog No.:BCC1385
CAS No.:1202757-89-8
- CNX-774
Catalog No.:BCC4394
CAS No.:1202759-32-7
- Btk inhibitor 1
Catalog No.:BCC4238
CAS No.:1412418-47-3
- QL47
Catalog No.:BCC3920
CAS No.:1469988-75-7
- Btk inhibitor 1 R enantiomer hydrochloride
Catalog No.:BCC5126
CAS No.:1553977-42-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 936563-87-0 | SDF | Download SDF |
PubChem ID | 16126651 | Appearance | Powder |
Formula | C25H24N6O2 | M.Wt | 440.5 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Ibrutinib Racemate | ||
Solubility | DMSO : 25 mg/mL (56.75 mM; Need ultrasonic) | ||
Chemical Name | 1-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one | ||
SMILES | C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N | ||
Standard InChIKey | XYFPWWZEPKGCCK-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | PCI-32765 Racemate is the racemate of PCI-32765. PCI-32765 is a selective, irreversible Btk inhibitor with IC50 value of 0.5 nM. References: |
PCI-32765 Racemate Dilution Calculator
PCI-32765 Racemate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.2701 mL | 11.3507 mL | 22.7015 mL | 45.403 mL | 56.7537 mL |
5 mM | 0.454 mL | 2.2701 mL | 4.5403 mL | 9.0806 mL | 11.3507 mL |
10 mM | 0.227 mL | 1.1351 mL | 2.2701 mL | 4.5403 mL | 5.6754 mL |
50 mM | 0.0454 mL | 0.227 mL | 0.454 mL | 0.9081 mL | 1.1351 mL |
100 mM | 0.0227 mL | 0.1135 mL | 0.227 mL | 0.454 mL | 0.5675 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
PCI-32765 is an inhibitor of Bruton tyrosine kinase (BTK) with IC50 value of 0.5nM [1].
PCI-32765 is a covalent and irreversible inhibitor of BTK through bonding to Cys-481 in the ATP binding domain. PCI-32765 inhibits phosphorylation of BTK in a B cells (IC50 of 11nM) as well as the downstream substrates phosphoinositide phospholipase Cγ (PLC γ) and ERK in cell assays. PCI-32765 has in vivo efficacy in B cell lymphoma. In CLL cells, PCI-32765 induces cells apoptosis through inhibiting the expression of BCR-dependent UDP-glucose ceramide glucosyltransferase [1].
PCI-32765 is oral effective in vivo. It induces lymphocytosis during the first weeks of therapy in patients with CLL. It is also efficacious in autoimmune disease. In the MRL-Fas lupus model, PCI-32765 inhibits collagen-induced arthritis as well as autoantibody production and development of kidney disease. It also diminished FcγRIII-induced production of pro-inflammatory cytokines [1].
References:
[1] Burger JA, Buggy JJ. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765). Leuk Lymphoma. 2013 Nov;54(11):2385-91.
- Ajuganipponin A
Catalog No.:BCN3660
CAS No.:936323-13-6
- ACET
Catalog No.:BCC7462
CAS No.:936095-50-0
- TG101348 (SAR302503)
Catalog No.:BCC2190
CAS No.:936091-26-8
- TG101209
Catalog No.:BCC2198
CAS No.:936091-14-4
- cAMPS-Sp, triethylammonium salt
Catalog No.:BCC8081
CAS No.:93602-66-5
- Daphnenone
Catalog No.:BCN3229
CAS No.:936006-13-2
- 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methylbut-1-enyl)benzene-1,3-diol
Catalog No.:BCN1304
CAS No.:936006-11-0
- Oprozomib (ONX-0912)
Catalog No.:BCC1146
CAS No.:935888-69-0
- AR-42 (OSU-HDAC42)
Catalog No.:BCC2161
CAS No.:935881-37-1
- BIX 01294
Catalog No.:BCC1131
CAS No.:935693-62-2
- AZD1480
Catalog No.:BCC2191
CAS No.:935666-88-9
- MDL 72527
Catalog No.:BCC6060
CAS No.:93565-01-6
- PCI-32765 (Ibrutinib)
Catalog No.:BCC1266
CAS No.:936563-96-1
- LCZ696
Catalog No.:BCC5505
CAS No.:936623-90-4
- VX-809
Catalog No.:BCC3712
CAS No.:936727-05-8
- Magnolignan A
Catalog No.:BCN4084
CAS No.:93673-81-5
- Rengyol
Catalog No.:BCN4481
CAS No.:93675-85-5
- Forsythoside E
Catalog No.:BCN2782
CAS No.:93675-88-8
- OSI-027
Catalog No.:BCC4603
CAS No.:936890-98-1
- Magnolignan C
Catalog No.:BCN4085
CAS No.:93697-42-8
- TC-H 106
Catalog No.:BCC2426
CAS No.:937039-45-7
- Leuconolam
Catalog No.:BCN4482
CAS No.:93710-27-1
- GSK690693
Catalog No.:BCC2483
CAS No.:937174-76-0
- NSC 95397
Catalog No.:BCC7109
CAS No.:93718-83-3